TipRanks
GlobeStar Therapeutics (GSTC)
OTHER OTC:GSTC
US Market
GSTC
GlobeStar Therapeutics
RESEARCH TOOLSreports

GlobeStar Therapeutics (GSTC) Ratios

17 Followers

GlobeStar Therapeutics Ratios

GSTC's free cash flow for Q3 2024 was $0.00. For the 2024 fiscal year, GSTC's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Sep 23Sep 22Sep 21Sep 20
Liquidity Ratios
Current Ratio
 0.00 0.00 <0.01 <0.01 0.12
Quick Ratio
 0.00 0.00 <0.01 <0.01 0.12
Cash Ratio
 0.00 0.00 <0.01 <0.01 0.11
Solvency Ratio
 -0.06 -0.06 -1.23 -13.39 -0.72
Operating Cash Flow Ratio
 -0.14 -0.14 -0.27 -1.03 -0.32
Short-Term Operating Cash Flow Coverage
 -0.56 -0.56 -16.35 -7.08 -1.55
Net Current Asset Value
$ -1.43M$ -1.43M$ -1.19M$ -725.82K$ -660.50K
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 2.02 17.81 1.72
Debt-to-Equity Ratio
 -0.26 -0.26 -0.02 -0.15 -0.24
Debt-to-Capital Ratio
 -0.34 -0.34 -0.02 -0.17 -0.31
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 0.00 0.00 >-0.01 >-0.01 -0.14
Debt Service Coverage Ratio
 0.01 0.01 -13.99 -23.10 -0.77
Interest Coverage Ratio
 -20.35 -20.35 -17.98 -31.63 -1.28
Debt to Market Cap
 2.95 0.25 <0.01 <0.01 0.08
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 54.43 54.43 -0.01 -0.01 -0.24
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%-48837.66%
EBIT Margin
0.00%0.00%0.00%0.00%-394805.19%
EBITDA Margin
0.00%0.00%0.00%0.00%-392207.79%
Operating Profit Margin
0.00%0.00%0.00%0.00%-394805.19%
Pretax Profit Margin
0.00%0.00%0.00%0.00%-703896.10%
Net Profit Margin
0.00%0.00%0.00%0.00%-703896.10%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%-703896.10%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
104.56%104.56%117.63%107.79%178.29%
Return on Assets (ROA)
0.00%0.00%-15007.56%-164463.09%-602.81%
Return on Equity (ROE)
148.30%135.93%124.56%1350.47%82.22%
Return on Capital Employed (ROCE)
130.00%130.00%105.90%1252.93%46.11%
Return on Invested Capital (ROIC)
174.56%174.56%107.70%1467.51%60.30%
Return on Tangible Assets
0.00%0.00%-15007.56%-164463.09%-602.81%
Earnings Yield
-2355.79%-130.88%-63.98%-68.69%-26.74%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.00 0.00 0.00 0.01 0.28
Inventory Turnover
 0.00 0.00 0.00 0.00 15.62
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.06
Asset Turnover
 0.00 0.00 0.00 0.00 <0.01
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 >-0.01
Cash Conversion Cycle
 0.00 0.00 0.00 -33.71K -1.27K
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 23.36
Days of Payables Outstanding
 0.00 0.00 0.00 33.71K 1.29K
Operating Cycle
 0.00 0.00 0.00 0.00 23.36
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
CapEx Per Share
 0.00 0.00 <0.01 0.00 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
 0.00 0.00 -65.40K 0.00 -134.53
Capital Expenditure Coverage Ratio
 0.00 0.00 -65.40K 0.00 -134.53
Operating Cash Flow Coverage Ratio
 -0.56 -0.56 -16.35 -7.08 -1.55
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 -3.11K
Free Cash Flow Yield
-165.79%-13.82%-14.06%-5.26%-11.91%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.04 -0.76 -1.56 -1.46 -3.74
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 26.32K
Price-to-Book (P/B) Ratio
 -0.06 -1.04 -1.95 -19.66 -3.07
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.60 -7.24 -7.11 -19.00 -8.39
Price-to-Operating Cash Flow Ratio
 -0.40 -7.24 -7.11 -19.00 -8.46
Price-to-Earnings Growth (PEG) Ratio
 >-0.01 0.00 0.02 >-0.01 0.05
Price-to-Fair Value
 -0.06 -1.04 -1.95 -19.66 -3.07
Enterprise Value Multiple
 72.89 275.91 -1.85 -1.58 -6.96
Enterprise Value
 490.12K 1.86M 2.34M 14.37M 2.10M
EV to EBITDA
 72.89 275.91 -1.85 -1.58 -6.96
EV to Sales
 0.00 0.00 0.00 0.00 27.28K
EV to Free Cash Flow
 -2.38 -9.02 -7.15 -19.13 -8.70
EV to Operating Cash Flow
 -2.38 -9.02 -7.15 -19.13 -8.76
Tangible Book Value Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Shareholders’ Equity Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.00 0.00 0.00 0.00 <0.01
Net Income Per Share
 >-0.01 >-0.01 >-0.01 -0.02 >-0.01
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.05 1.05 1.18 1.08 1.78
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 3.46K
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 461.04
Income Quality
 0.11 0.11 0.22 0.08 0.44
Currency in USD